High efficiency base editors comprising Gam Grant US-11932884-B2 United States of America 19 Mar 2024
Methods and compositions for simultaneous editing of both strands of a target double-strand… Grant US-11912985-B2 United States of America 27 Feb 2024
Editing of CCR2 receptor gene to protect against HIV infection Grant US-11820969-B2 United States of America 21 Nov 2023
Methods and compositions for prime editing nucleotide sequences Grant US-11795452-B2 United States of America 24 Oct 2023
Methods and compositions for evolving base editors using phage-assisted continuous… Grant US-11732274-B2 United States of America 22 Aug 2023
Adenosine nucleobase editors and uses thereof Grant US-11702651-B2 United States of America 18 Jul 2023
Programmable CAS9-recombinase fusion proteins and uses thereof Grant US-11661590-B2 United States of America 30 May 2023
Nme2Cas9 INLAID DOMAIN FUSION PROTEINS Application WO-2023081070-A1 World Intellectual Property Organisation (WIPO) 11 May 2023
Methods and compositions for prime editing nucleotide sequences Grant US-11643652-B2 United States of America 09 May 2023
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and… Grant US-11560566-B2 United States of America 24 Jan 2023
Incorporation of unnatural amino acids into proteins using base editing Grant US-11542509-B2 United States of America 03 Jan 2023
CAS13-BASED COMPOSITIONS AND METHODS OF USE THEREOF Application WO-2022249152-A2 World Intellectual Property Organisation (WIPO) 01 Dec 2022
Methods and compositions for prime editing nucleotide sequences Grant US-11447770-B1 United States of America 20 Sep 2022
High efficiency base editors comprising Gam Grant US-11319532-B2 United States of America 03 May 2022
Nucleobase editors comprising nucleic acid programmable DNA binding proteins Grant US-11268082-B2 United States of America 08 Mar 2022
NUCLEOBASE EDITORS COMPRISING GEOCAS9 AND USES THEREOF Application WO-2020092453-A1 World Intellectual Property Organisation (WIPO) 07 May 2020
PROGRAMMABLE DNA BASE EDITING BY NME2CAS9-DEAMINASE FUSION PROTEINS Application WO-2020081568-A1 World Intellectual Property Organisation (WIPO) 23 Apr 2020
THERMOSTABLE CAS9 NUCLEASES WITH REDUCED OFF-TARGET ACTIVITY Application WO-2019072596-A1 World Intellectual Property Organisation (WIPO) 18 Apr 2019